首页> 美国卫生研究院文献>International Journal of Biomedical Science : IJBS >Hormone-Balancing Effect of Pre-Gelatinized Organic Maca (Lepidium peruvianum Chacon): (III) Clinical responses of early-postmenopausal women to Maca in double blind randomized Placebo-controlled crossover configuration outpatient study
【2h】

Hormone-Balancing Effect of Pre-Gelatinized Organic Maca (Lepidium peruvianum Chacon): (III) Clinical responses of early-postmenopausal women to Maca in double blind randomized Placebo-controlled crossover configuration outpatient study

机译:预先糊化的有机玛卡(Lepidium peruvianum Chacon)的激素平衡作用:(III)绝经后早期妇女在双盲随机安慰剂对照交叉配置门诊研究中对玛卡的临床反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This is the second, conclusive part of the clinical study on clinical responses of early-postmenopausal women to standardized doses of pre-Gelatinized Organic Maca (Maca-GO). Total of 34 Caucasian women volunteers participated in a double-blind, randomized, four months outpatient crossover configuration Trial. After fulfilling the criteria of being early-postmenopausal: blood Estrogen (E2<40 pg/ml) and Follicle Stimulating Hormone (FSH>30 IU/ml) at admission, they were randomly allocated to Placebo (P) and Maca-GO (M) treatments (2 groups of 11 participants each). Two 500 mg vegetable hard gel capsules with Maca-GO or Placebo powder were self-administered twice daily with meals (total 2 g/day). At admission and follow-up monthly intervals, body mass index (BMI), blood pressure, levels of gonadal, pituitary, thyroid and adrenal hormones, lipids and key minerals were measured. Bone markers were determined after four months M and P use in 12 participants. Menopausal symptoms were assessed according to Greene’s Score (GMS) and Kupperman’s Index (KMI). Data were analyzed using multivariate technique on blocs of monthly. Results and canonical variate technique was applied to GMS and KMI matrices. Two months application of Maca-GO stimulated (P<0.05) production of E2, suppressed (P<0.05) blood FSH, Thyroid (T3) and Adrenocorticotropic hormones, Cortisol, and BMI, increased (P<0.05) low density lipoproteins, blood Iron and alleviated (P<0.001) menopausal symptoms. Maca-GO noticeably increased bone density markers. In conclusion, Maca-GO applied to early-postmenopausal women (i) acted as a toner of hormonal processes along the Hypothalamus-Pituitary-Ovarian axis, (ii) balanced hormone levels and (iii) relieved symptoms of menopausal discomfort, (hot flushes and night sweating in particular), thus, (iv) exhibited a distinctive function peculiar to adaptogens, providing an alternative non-hormonal plant option to reduce dependence on hormone therapy programs (HRT).
机译:这是绝经后早期妇女对标准化剂量的预明胶化有机Maca(Maca-GO)的临床反应的第二个结论性研究。共有34名白人女性志愿者参加了一项双盲,随机,四个月的门诊交叉配置试验。满足绝经后早期的标准:入院时的血液雌激素(E2 <40 pg / ml)和促卵泡激素(FSH> 30 IU / ml)后,将它们随机分配给安慰剂(P)和Maca-GO(M )治疗(2组,每组11名参与者)。每天两次随餐自给两次含Maca-GO或安慰剂粉末的500 mg蔬菜硬凝胶胶囊(总计2 g /天)。在入院和随访的每月间隔中,测量体重指数(BMI),血压,性腺,垂体,甲状腺和肾上腺激素,脂质和主要矿物质的水平。在12名参与者使用M和P四个月后确定骨标记。根据格林分数(GMS)和库珀曼指数(KMI)评估更年期症状。使用多元技术对月度集团进行数据分析。将结果和规范变量技术应用于GMS和KMI矩阵。施用Maca-GO两个月可刺激(P <0.05)E2产生,抑制(P <0.05)血液中的FSH,甲状腺(T3)和促肾上腺皮质激素,皮质醇和BMI,增加(P <0.05)低密度脂蛋白,血液铁和缓解(P <0.001)的更年期症状。 Maca-GO显着增加了骨密度标记。总之,Maca-GO适用于绝经后早期妇女(i)充当下丘脑-垂体-卵巢轴上激素过程的调色剂,(ii)平衡的激素水平和(iii)缓解更年期不适症状(潮热)因此,(iv)表现出适应原特有的独特功能,为减少对激素治疗计划(HRT)的依赖提供了另一种非激素植物选择。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号